<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Supraoptic Nucleus Oxytocin Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hypothalamic Neuroendocrine Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Supraoptic nucleus, paraventricular nucleus</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Magnocellular oxytocin neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Oxytocin (OT)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Oxytocin, neurophysin I, OTR</td>
</tr>
<tr>
<td class="label">Projection</td>
<td>Posterior pituitary (neurohypophysis), central projections</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Autonomic and endocrine regulation</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Emotional processing, fear extinction</td>
</tr>
<tr>
<td class="label">Nucleus accumbens</td>
<td>Reward, social bonding</td>
</tr>
<tr>
<td class="label">Ventral tegmental area</td>
<td>Motivation, social reward</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Social memory, context processing</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Oxytocin (OT)</td>
<td>Primary peptide hormone</td>
</tr>
<tr>
<td cla
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Supraoptic Nucleus Oxytocin Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hypothalamic Neuroendocrine Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Supraoptic nucleus, paraventricular nucleus</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Magnocellular oxytocin neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Oxytocin (OT)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Oxytocin, neurophysin I, OTR</td>
</tr>
<tr>
<td class="label">Projection</td>
<td>Posterior pituitary (neurohypophysis), central projections</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Autonomic and endocrine regulation</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Emotional processing, fear extinction</td>
</tr>
<tr>
<td class="label">Nucleus accumbens</td>
<td>Reward, social bonding</td>
</tr>
<tr>
<td class="label">Ventral tegmental area</td>
<td>Motivation, social reward</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Social memory, context processing</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Oxytocin (OT)</td>
<td>Primary peptide hormone</td>
</tr>
<tr>
<td class="label">Neurophysin I</td>
<td>Carrier protein</td>
</tr>
<tr>
<td class="label">OXTR</td>
<td>Oxytocin receptor</td>
</tr>
<tr>
<td class="label">OXT mRNA</td>
<td>Gene expression</td>
</tr>
<tr>
<td class="label">Intervention</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Intranasal oxytocin</td>
<td>Clinical use</td>
</tr>
<tr>
<td class="label">Oxytocin analogues</td>
<td>Investigational</td>
</tr>
<tr>
<td class="label">OXTR agonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Experimental</td>
</tr>
</table>
The supraoptic nucleus (SON) oxytocin [neurons](/entities/neurons) constitute a major population of hypothalamic neurosecretory cells that synthesize and release oxytocin, a peptide hormone critical for social bonding, reproductive functions, stress regulation, and emotional processing. Located in the anterior hypothalamus adjacent to the optic chiasm, these magnocellular neurons project their axons directly to the posterior pituitary gland, where they release oxytocin into the systemic circulation. Oxytocin neurons represent approximately 30-40% of the SON neuronal population in humans, with the remainder being vasopressin-producing cells. The dysfunction of oxytocin neurons has been increasingly recognized in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease-disease), and frontotemporal dementia, where social cognitive deficits and autonomic dysfunction are prominent features. [@donaldson2011]
The supraoptic nucleus oxytocin neurons are characterized by:
Oxytocin neurons also reside in the paraventricular nucleus (PVN):
SON oxytocin neurons receive diverse synaptic inputs:
Oxytocin neurons implement a precise biosynthesis pathway:
Oxytocin released from the posterior pituitary mediates:
Centrally released oxytocin modulates:
Oxytocin receptors (OXTR) are widely distributed:
Oxytocin neurons and the oxytocin system are altered in AD:
PD demonstrates significant oxytocin system involvement:
FTD shows prominent oxytocin system alterations:
While not strictly neurodegenerative, ASD shows:
Oxytocin receptor (OXTR) signals through:
The study of Supraoptic Nucleus Oxytocin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving Supraoptic Nucleus Oxytocin Neurons discovered through SciDEX knowledge graph analysis: